CELGENE CAR LLC

Organization

PEMBROKE, BM

Organizations

Please log in for detailed analytics

Patents Grantslast 30 patents

Information Patent Grant
MK2 inhibitors, synthesis thereof, and intermediates thereto
- Patent number 11,655,257
- Issue date May 23, 2023
- Celgene CAR LLC
- Gregg Brian Feigelson
- C07 - ORGANIC CHEMISTRY
Information Patent Grant
Forms and compositions of a MK2 inhibitor
- Patent number 11,629,153
- Issue date Apr 18, 2023
- Celgene CAR LLC
- Jianxin Han
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Grant
MK2 inhibitors and uses thereof
- Patent number 11,584,757
- Issue date Feb 21, 2023
- Celgene CAR LLC
- Matthew David Alexander
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Grant
Ligand-directed covalent modification of protein
- Patent number 11,542,492
- Issue date Jan 3, 2023
- Celgene CAR LLC
- Russell C. Petter
- C12 - BIOCHEMISTRY BEER SPIRITS WINE VINEGAR MICROBIOLOGY ENZYMOLOGY MUTATION...
Information Patent Grant
2,4-disubstituted pyrimidines useful as kinase inhibitors
- Patent number 11,351,168
- Issue date Jun 7, 2022
- Celgene CAR LLC
- Juswinder Singh
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Grant
Salts of an epidermal growth factor receptor kinase inhibitor
- Patent number 11,292,772
- Issue date Apr 5, 2022
- Celgene CAR LLC
- Mei Lai
- C07 - ORGANIC CHEMISTRY
Information Patent Grant
Deuterated analogs of MK2 inhibitors and uses thereof
- Patent number 11,230,551
- Issue date Jan 25, 2022
- Celgene CAR LLC
- John Malona
- C07 - ORGANIC CHEMISTRY
Information Patent Grant
Heteroaryl compounds useful as MK2 inhibitors
- Patent number 11,124,525
- Issue date Sep 21, 2021
- Celgene CAR LLC
- Jian Guo
- C07 - ORGANIC CHEMISTRY
Information Patent Grant
9,10,11,12-tetrahydro-8H-[1,4]diazepino[5′,6′:4,5]thieno[3,2-F]quin...
- Patent number 11,098,057
- Issue date Aug 24, 2021
- Celgene CAR LLC
- John Malona
- C07 - ORGANIC CHEMISTRY
Information Patent Grant
MK2 inhibitors and uses thereof
- Patent number 11,098,061
- Issue date Aug 24, 2021
- Celgene CAR LLC
- Matthew David Alexander
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Grant
Heterocyclic compounds and uses thereof
- Patent number 11,096,942
- Issue date Aug 24, 2021
- Celgene CAR LLC
- Kwangho Lee
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Grant
Solid forms of an epidermal growth factor receptor kinase inhibitor
- Patent number 10,946,016
- Issue date Mar 16, 2021
- Celgene CAR LLC
- Mei Lai
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Grant
MK2 inhibitors, synthesis thereof, and intermediates thereto
- Patent number 10,894,796
- Issue date Jan 19, 2021
- Celgene CAR LLC
- Gregg Brian Feigelson
- C07 - ORGANIC CHEMISTRY
Information Patent Grant
Forms and compositions of a MK2 inhibitor
- Patent number 10,882,867
- Issue date Jan 5, 2021
- Celgene CAR LLC
- Jianxin Han
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Grant
Substituted 2,4-diaminopyrimidines as kinase inhibitors
- Patent number 10,828,300
- Issue date Nov 10, 2020
- Celgene CAR LLC
- Juswinder Singh
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Grant
Heteroaryl compounds and uses thereof
- Patent number 10,774,052
- Issue date Sep 15, 2020
- Celgene CAR LLC
- Laura Akullian D'Agostino
- C07 - ORGANIC CHEMISTRY
Information Patent Grant
Protein kinase conjugates and inhibitors
- Patent number 10,662,195
- Issue date May 26, 2020
- Celgene CAR LLC
- Juswinder Singh
- C12 - BIOCHEMISTRY BEER SPIRITS WINE VINEGAR MICROBIOLOGY ENZYMOLOGY MUTATION...
Information Patent Grant
Substituted pyrido[2,3-d]pyrimidines as inhibitors of protein kinases
- Patent number 10,618,902
- Issue date Apr 14, 2020
- Celgene CAR LLC
- Laura Akullian D'Agostino
- C07 - ORGANIC CHEMISTRY
Information Patent Grant
2,4-disubstituted pyrimidines useful as kinase inhibitors
- Patent number 10,596,172
- Issue date Mar 24, 2020
- Celgene CAR LLC
- Juswinder Singh
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Grant
MK2 inhibitors and uses thereof
- Patent number 10,577,380
- Issue date Mar 3, 2020
- Celgene CAR LLC
- Matthew David Alexander
- C07 - ORGANIC CHEMISTRY
Information Patent Grant
Salts of an epidermal growth factor receptor kinase inhibitor
- Patent number 10,570,099
- Issue date Feb 25, 2020
- Celgene CAR LLC
- Mei Lai
- C07 - ORGANIC CHEMISTRY
Information Patent Grant
Heterocyclic compounds and uses thereof
- Patent number 10,434,101
- Issue date Oct 8, 2019
- Celgene CAR LLC
- Kwangho Lee
- C07 - ORGANIC CHEMISTRY
Information Patent Grant
MK2 inhibitors and uses thereof
- Patent number 10,253,040
- Issue date Apr 9, 2019
- Celgene CAR LLC
- Matthew David Alexander
- C07 - ORGANIC CHEMISTRY
Information Patent Grant
Forms and compositions of an ERK inhibitor
- Patent number 10,202,364
- Issue date Feb 12, 2019
- Celgene CAR LLC
- Antonio Christian Ferretti
- C07 - ORGANIC CHEMISTRY
Information Patent Grant
Heteroaryl compounds and uses thereof
- Patent number 10,189,794
- Issue date Jan 29, 2019
- Celgene CAR LLC
- Laura Akullian D'Agostino
- C07 - ORGANIC CHEMISTRY
Information Patent Grant
MK2 inhibitors and uses thereof
- Patent number 10,138,256
- Issue date Nov 27, 2018
- Celgene CAR LLC
- Matthew David Alexander
- C07 - ORGANIC CHEMISTRY
Information Patent Grant
Heteroaryl compounds and uses thereof
- Patent number 10,081,606
- Issue date Sep 25, 2018
- Celgene CAR LLC
- Kwangho Lee
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Grant
Substituted pyrido[2,3-d]pyrimidines as inhibitors of protein kinases
- Patent number 10,065,966
- Issue date Sep 4, 2018
- Celgene CAR LLC
- Laura Akullian D'Agostino
- C07 - ORGANIC CHEMISTRY
Information Patent Grant
2,4-disubstituted pyrimidines useful as kinase inhibitors
- Patent number 10,010,548
- Issue date Jul 3, 2018
- Celgene CAR LLC
- Juswinder Singh
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Grant
Forms and compositions of an ERK inhibitor
- Patent number 10,005,760
- Issue date Jun 26, 2018
- Celgene CAR LLC
- Antonio Christian Ferretti
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE

Please log in for detailed analytics

Patents Applicationslast 30 patents

Information Patent Application
HETEROARYL COMPOUNDS AND USES THEREOF
- Publication number 20220332687
- Publication date Oct 20, 2022
- Celgene CAR LLC
- Laura Akullian D'Agostino
- C07 - ORGANIC CHEMISTRY
Information Patent Application
METHODS OF TREATING A MK2-MEDIATED DISORDER
- Publication number 20220251105
- Publication date Aug 11, 2022
- Celgene CAR LLC
- Francisco Ramirez-Valle
- C07 - ORGANIC CHEMISTRY
Information Patent Application
HETEROCYCLIC COMPOUNDS AND USES THEREOF
- Publication number 20220218704
- Publication date Jul 14, 2022
- Celgene CAR LLC
- Kwangho Lee
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
SOLID FORMS OF AN EPIDERMAL GROWTH FACTOR RECEPTOR KINASE INHIBITOR
- Publication number 20220062280
- Publication date Mar 3, 2022
- Celgene CAR LLC
- Mei Lai
- C07 - ORGANIC CHEMISTRY
Information Patent Application
HETEROARYL COMPOUNDS USEFUL AS MK2 INHIBITORS
- Publication number 20220064183
- Publication date Mar 3, 2022
- Celgene CAR LLC
- Jian Guo
- C07 - ORGANIC CHEMISTRY
Information Patent Application
FORMS AND COMPOSITIONS OF A MK2 INHIBITOR
- Publication number 20210198276
- Publication date Jul 1, 2021
- Celgene CAR LLC
- Jianxin Han
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
MK2 INHIBITORS, SYNTHESIS THEREOF, AND INTERMEDIATES THERETO
- Publication number 20210139501
- Publication date May 13, 2021
- Celgene CAR LLC
- Gregg Brian Feigelson
- C07 - ORGANIC CHEMISTRY
Information Patent Application
DEUTERATED ANALOGS OF MK2 INHIBITORS AND USES THEREOF
- Publication number 20210122762
- Publication date Apr 29, 2021
- Celgene CAR LLC
- John Malona
- C07 - ORGANIC CHEMISTRY
Information Patent Application
MK2 INHIBITORS AND USES THEREOF
- Publication number 20210053984
- Publication date Feb 25, 2021
- Celgene CAR LLC
- Matthew David Alexander
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
SALTS OF AN EPIDERMAL GROWTH FACTOR RECEPTOR KINASE INHIBITOR
- Publication number 20210017137
- Publication date Jan 21, 2021
- Celgene CAR LLC
- Mei Lai
- C07 - ORGANIC CHEMISTRY
Information Patent Application
HETEROCYCLIC COMPOUNDS AND USES THEREOF
- Publication number 20200276194
- Publication date Sep 3, 2020
- Celgene CAR LLC
- Kwangho Lee
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
FORMS AND COMPOSITIONS OF A MK2 INHIBITOR
- Publication number 20200148701
- Publication date May 14, 2020
- Celgene CAR LLC
- Jianxin Han
- C07 - ORGANIC CHEMISTRY
Information Patent Application
HETEROARYL COMPOUNDS USEFUL AS MK2 INHIBITORS
- Publication number 20200102325
- Publication date Apr 2, 2020
- Celgene CAR LLC
- Jian Guo
- C07 - ORGANIC CHEMISTRY
Information Patent Application
MK2 INHIBITORS, SYNTHESIS THEREOF, AND INTERMEDIATES THERETO
- Publication number 20200102326
- Publication date Apr 2, 2020
- Celgene CAR LLC
- Gregg Brian Feigelson
- C07 - ORGANIC CHEMISTRY
Information Patent Application
9,10,11,12-TETRAHYDRO-8H-[1,4]DIAZEPINO[5',6':4,5]THIENO[3,2-F]QUIN...
- Publication number 20200102327
- Publication date Apr 2, 2020
- Celgene CAR LLC
- John Malona
- C07 - ORGANIC CHEMISTRY
Information Patent Application
MK2 INHIBITORS AND USES THEREOF
- Publication number 20190375762
- Publication date Dec 12, 2019
- Celgene CAR LLC
- Matthew David Alexander
- C07 - ORGANIC CHEMISTRY
Information Patent Application
HETEROARYL COMPOUNDS AND USES THEREOF
- Publication number 20190375719
- Publication date Dec 12, 2019
- Celgene CAR LLC
- Laura Akullian D'Agostino
- C07 - ORGANIC CHEMISTRY
Information Patent Application
HETEROARYL COMPOUNDS AND USES THEREOF
- Publication number 20190218220
- Publication date Jul 18, 2019
- Celgene CAR LLC
- Laura Akullian D'Agostino
- C07 - ORGANIC CHEMISTRY
Information Patent Application
HETEROARYL COMPOUNDS AND USES THEREOF
- Publication number 20190192512
- Publication date Jun 27, 2019
- Celgene CAR LLC
- Juswinder Singh
- C07 - ORGANIC CHEMISTRY
Information Patent Application
SOLID FORMS OF AN EPIDERMAL GROWTH FACTOR RECEPTOR KINASE INHIBITOR
- Publication number 20190151313
- Publication date May 23, 2019
- Celgene CAR LLC
- Mei Lai
- C07 - ORGANIC CHEMISTRY
Information Patent Application
SALTS OF AN EPIDERMAL GROWTH FACTOR RECEPTOR KINASE INHIBITOR
- Publication number 20190152925
- Publication date May 23, 2019
- Celgene CAR LLC
- Mei Lai
- C07 - ORGANIC CHEMISTRY
Information Patent Application
MK2 INHIBITORS AND USES THEREOF
- Publication number 20190135835
- Publication date May 9, 2019
- Celgene CAR LLC
- Matthew David Alexander
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
HETEROARYL COMPOUNDS AND USES THEREOF
- Publication number 20190117650
- Publication date Apr 25, 2019
- Celgene CAR LLC
- Juswinder Singh
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
FORMS AND COMPOSITIONS OF AN ERK INHIBITOR
- Publication number 20180362498
- Publication date Dec 20, 2018
- Celgene CAR LLC
- Antonio Christian Ferretti
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
HETEROCYCLIC COMPOUNDS AND USES THEREOF
- Publication number 20180353508
- Publication date Dec 13, 2018
- Celgene CAR LLC
- Kwangho Lee
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
HETEROARYL COMPOUNDS AND USES THEREOF
- Publication number 20180072687
- Publication date Mar 15, 2018
- Celgene CAR LLC
- Kwangho Lee
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
HETEROARYL COMPOUNDS AND USES THEREOF
- Publication number 20180022713
- Publication date Jan 25, 2018
- Celgene CAR LLC
- Laura Akullian D'Agostino
- C12 - BIOCHEMISTRY BEER SPIRITS WINE VINEGAR MICROBIOLOGY ENZYMOLOGY MUTATION...
Information Patent Application
SOLID FORMS OF AN EPIDERMAL GROWTH FACTOR RECEPTOR KINASE INHIBITOR
- Publication number 20170281623
- Publication date Oct 5, 2017
- Celgene CAR LLC
- Mei Lai
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
HETEROARYL COMPOUNDS AND USES THEREOF
- Publication number 20170267685
- Publication date Sep 21, 2017
- Celgene CAR LLC
- Laura Akullian D'Agostino
- C07 - ORGANIC CHEMISTRY
Information Patent Application
FORMS AND COMPOSITIONS OF AN ERK INHIBITOR
- Publication number 20170226083
- Publication date Aug 10, 2017
- Celgene CAR LLC
- Antonio Christian Ferretti
- C07 - ORGANIC CHEMISTRY

CELGENE CAR LLC

Organization

Patents Grantslast 30 patents

MK2 inhibitors, synthesis thereof, and intermediates thereto

Forms and compositions of a MK2 inhibitor

MK2 inhibitors and uses thereof

Ligand-directed covalent modification of protein

2,4-disubstituted pyrimidines useful as kinase inhibitors

Salts of an epidermal growth factor receptor kinase inhibitor

Deuterated analogs of MK2 inhibitors and uses thereof

Heteroaryl compounds useful as MK2 inhibitors

9,10,11,12-tetrahydro-8H-[1,4]diazepino[5′,6′:4,5]thieno[3,2-F]quin...

MK2 inhibitors and uses thereof

Heterocyclic compounds and uses thereof

Solid forms of an epidermal growth factor receptor kinase inhibitor

MK2 inhibitors, synthesis thereof, and intermediates thereto

Forms and compositions of a MK2 inhibitor

Substituted 2,4-diaminopyrimidines as kinase inhibitors

Heteroaryl compounds and uses thereof

Protein kinase conjugates and inhibitors

Substituted pyrido[2,3-d]pyrimidines as inhibitors of protein kinases

2,4-disubstituted pyrimidines useful as kinase inhibitors

MK2 inhibitors and uses thereof

Salts of an epidermal growth factor receptor kinase inhibitor

Heterocyclic compounds and uses thereof

MK2 inhibitors and uses thereof

Forms and compositions of an ERK inhibitor

Heteroaryl compounds and uses thereof

MK2 inhibitors and uses thereof

Heteroaryl compounds and uses thereof

Substituted pyrido[2,3-d]pyrimidines as inhibitors of protein kinases

2,4-disubstituted pyrimidines useful as kinase inhibitors

Forms and compositions of an ERK inhibitor

Patents Applicationslast 30 patents

HETEROARYL COMPOUNDS AND USES THEREOF

METHODS OF TREATING A MK2-MEDIATED DISORDER

HETEROCYCLIC COMPOUNDS AND USES THEREOF

SOLID FORMS OF AN EPIDERMAL GROWTH FACTOR RECEPTOR KINASE INHIBITOR

HETEROARYL COMPOUNDS USEFUL AS MK2 INHIBITORS

FORMS AND COMPOSITIONS OF A MK2 INHIBITOR

MK2 INHIBITORS, SYNTHESIS THEREOF, AND INTERMEDIATES THERETO

DEUTERATED ANALOGS OF MK2 INHIBITORS AND USES THEREOF

MK2 INHIBITORS AND USES THEREOF

SALTS OF AN EPIDERMAL GROWTH FACTOR RECEPTOR KINASE INHIBITOR

HETEROCYCLIC COMPOUNDS AND USES THEREOF

FORMS AND COMPOSITIONS OF A MK2 INHIBITOR

HETEROARYL COMPOUNDS USEFUL AS MK2 INHIBITORS

MK2 INHIBITORS, SYNTHESIS THEREOF, AND INTERMEDIATES THERETO

9,10,11,12-TETRAHYDRO-8H-[1,4]DIAZEPINO[5',6':4,5]THIENO[3,2-F]QUIN...

MK2 INHIBITORS AND USES THEREOF

HETEROARYL COMPOUNDS AND USES THEREOF

HETEROARYL COMPOUNDS AND USES THEREOF

HETEROARYL COMPOUNDS AND USES THEREOF

SOLID FORMS OF AN EPIDERMAL GROWTH FACTOR RECEPTOR KINASE INHIBITOR

SALTS OF AN EPIDERMAL GROWTH FACTOR RECEPTOR KINASE INHIBITOR

MK2 INHIBITORS AND USES THEREOF

HETEROARYL COMPOUNDS AND USES THEREOF

FORMS AND COMPOSITIONS OF AN ERK INHIBITOR

HETEROCYCLIC COMPOUNDS AND USES THEREOF

HETEROARYL COMPOUNDS AND USES THEREOF

HETEROARYL COMPOUNDS AND USES THEREOF

SOLID FORMS OF AN EPIDERMAL GROWTH FACTOR RECEPTOR KINASE INHIBITOR

HETEROARYL COMPOUNDS AND USES THEREOF

FORMS AND COMPOSITIONS OF AN ERK INHIBITOR